Free Trial

Myriad Genetics (MYGN) Insider Trading & Ownership

Myriad Genetics logo
$15.30 +0.30 (+2.00%)
(As of 11/20/2024 ET)

Myriad Genetics (NASDAQ:MYGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$5.47 M
Get MYGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Myriad Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MYGN Insider Buying and Selling by Quarter

Myriad Genetics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/11/2024Paul J DiazCEOSell15,000$22.93$343,950.00  
9/9/2024Heinrich DreismannDirectorSell10,000$27.05$270,500.00  
9/3/2024Colleen F ReitanDirectorSell46,012$27.95$1,286,035.40  
6/3/2024Daniel K SpiegelmanDirectorSell3,788$22.04$83,487.52  
5/15/2024Paul J DiazCEOSell75,000$25.07$1,880,250.00  
5/13/2024Lee Nisley NewcomerDirectorSell6,200$25.30$156,860.00  
5/13/2024Paul J DiazCEOSell57,844$25.13$1,453,619.72  
(Data available from 1/1/2013 forward)

MYGN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Myriad Genetics includes Colleen F Reitan, Daniel K Spiegelman, Heinrich Dreismann, Jayne B Hart, Lee Nisley Newcomer, Nicole Lambert, Paul J Diaz, and Richard Bryan Riggsbee. Learn more on insiders at MYGN.

2.10% of Myriad Genetics stock is owned by insiders. Learn more on MYGN's insider holdings.

The following insiders have sold MYGN shares in the last 24 months: Colleen F Reitan ($1,286,035.40), Daniel K Spiegelman ($282,247.90), Heinrich Dreismann ($270,500.00), Lee Nisley Newcomer ($156,860.00), Nicole Lambert ($151,046.84), Paul J Diaz ($3,677,819.72), and Richard Bryan Riggsbee ($974,082.00).

Insiders have sold a total of 288,915 Myriad Genetics shares in the last 24 months for a total of $6,798,591.86 sold.

Myriad Genetics Key Executives

  • Mr. Paul J. Diaz (Age 62)
    CEO, President & Director
    Compensation: $2.31M
    1 recent trades
  • Mr. Samraat S. Raha (Age 51)
    Chief Operating Officer
    Compensation: $514.76k
  • Dr. Dale Muzzey Ph.D. (Age 44)
    Chief Scientific Officer
    Compensation: $816.5k
  • Mr. Mark S. Verratti (Age 56)
    Chief Commercial Officer
    Compensation: $915.81k
  • Mr. Scott J. Leffler (Age 49)
    Chief Financial Officer
  • Ms. Natalie Munk (Age 43)
    Principal Accounting Officer
  • Dr. Kevin Richard Haas Ph.D. (Age 38)
    Chief Technology Officer
    Compensation: $580.36k
  • Mr. Matthew Scalo
    Senior Vice President of Investor Relations
  • Mr. Glenn Farrell
    Senior VP & Chief Marketing Officer
  • Ms. Shereen Solaiman (Age 51)
    Chief People Officer


This page (NASDAQ:MYGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners